300255 常山药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.486-25.874-14.789-50.9360.572
总资产报酬率 ROA (%)0.134-8.066-5.471-23.3290.312
投入资产回报率 ROIC (%)0.151-8.939-5.997-25.3300.334

边际利润分析
销售毛利率 (%)24.59815.13116.10322.50244.421
营业利润率 (%)1.853-40.030-24.645-86.9460.875
息税前利润/营业总收入 (%)11.816-30.118-15.118-80.7374.810
净利润/营业总收入 (%)1.320-41.989-25.614-88.4940.435

收益指标分析
经营活动净收益/利润总额(%)-48.98554.21784.07548.289164.295
价值变动净收益/利润总额(%)0.000-0.470-12.939-0.0010.000
营业外收支净额/利润总额(%)8.7861.5681.1810.436-12.896

偿债能力分析
流动比率 (X)0.7420.6890.9091.1852.180
速动比率 (X)0.2490.1930.2800.3290.820
资产负债率 (%)73.60473.15566.04460.84649.402
带息债务/全部投入资本 (%)66.97965.72259.45654.90444.558
股东权益/带息债务 (%)45.72947.62663.15079.332121.839
股东权益/负债合计 (%)37.04237.82952.30264.777102.558
利息保障倍数 (X)1.208-2.855-1.539-12.2521.192

营运能力分析
应收账款周转天数 (天)97.053103.24780.28377.32453.402
存货周转天数 (天)562.305634.519630.661671.176653.827